Effect of naftopidil on levels of MIP-2 and MIP-1αin serum and succus prostaticus in the treatment of prostatitis in elderly
10.3969/j.issn.1005-1678.2016.04.28
- VernacularTitle:萘哌地尔对老年前列腺炎患者血清及前列腺液MIP－2、MIP－1α水平的影响
- Author:
Minjie CHENG
;
Hong LI
- Publication Type:Journal Article
- Keywords:
prostatitis;
naftopidil;
MIP-2;
MIP-1α
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(4):95-96,99
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of naftopidil in the treatment of prostatitis in the elderly on MIP-2 and MIP-1αin serum and succus prostaticus.Methods 78 elderly patients with chronic prostatitis were randomly divided into the control group and the observation group, 39 cases in each group.The control group were treated with Diosmin routine treatment, the observation group were treated on the basis of the control group combined with naftopidil tablets in the treatment,2 groups were treated continuous for 8 weeks.MIP-2 and MIP-1αin serum and prostatic fluid before and after treatment were compared, and the maximum urine flow rate and clinical efficacy were compared after the treatment.Results compared with pre-treatment, MIP-2, MIP-1αin serum and prostate fluid in 2 groups after treatment decreased, NIH-CPSI and QOL scores in 2 groups decreased, the maximum urinary flow rate increased (P<0.05);compared with the control group, the levels of MIP-2, MIP-1αin the serum and prostatic fluid, NIH-CPSI and QOL of observation group were lower, and the maximum urine flow rate was higher (P<0.05);Compared with the control group, the total efficiency of the observation group was higher (P<0.05).Conclusion Naftopidil can significantly reduce the elderly patients with chronic non bacterial prostatitis and serum of patients with prostatic fluid MIP-2, MIP-1αlevel and improve pain in urination, dysuria symptoms.
